Opportunity
SAM #75N98026Q01135
NIH Solicitation for Olink Explore HT Blood Protein Testing and Data Analysis
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
September 02, 2026
Respond By
September 14, 2026
Identifier
75N98026Q01135
NAICS
541380, 541715, 541714
NIH's National Heart, Lung, and Blood Institute (NHLBI) Hematology Branch is seeking high-throughput blood protein testing and preliminary biostatistical analysis for research purposes. - Government Buyer: - National Institutes of Health (NIH), Office of the Director, Office of Acquisitions - National Heart, Lung, and Blood Institute (NHLBI) Hematology Branch - OEMs and Vendors: - Olink Proteomics Inc. (OEM) - Olink-certified service provider laboratories - Products/Services Requested: - High-throughput proteomic screening and preliminary biostatistical analysis of approximately 258 anonymized human plasma and bone marrow plasma samples - Use of Olink Explore HT platform (brand-name restricted) - Data delivery in Normalized Protein Expression (NPX) format - Biostatistical support including quality control, correlation/difference analysis, and first-pass filtering for clinical, biological, or statistical significance - Unique/Notable Requirements: - Strict brand-name restriction to Olink Explore HT platform due to assay chemistry and data comparability - Only Olink Proteomics Inc. and Olink-certified service providers are eligible - Initial data delivery required within 3 months of sample receipt; final data and analysis within 12 months - Approximately 258 samples to be processed and analyzed
Description
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.(ii) The solicitation number is 75N98026Q01135. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a purchase order resulting from this solicitation on a competitive basis limited to the OlinkĀ® Explore HT platform under the brand-name authority of FAR 13.106-1(b)(1). The associated brand-name justification is posted with this notice in accordance with FAR 5.102(a)(6). Competition is open to Olink Proteomics Inc. and all currently Olink-certified service provider laboratories capable of delivering OlinkĀ® Explore HT data meeting the specifications below.This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and Simplified Acquisition Procedures at FAR Subpart 13.5. The total estimated value is below the Simplified Acquisition Threshold.The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a firm-fixed-price purchase order to the responsible offeror whose proposal represents the best value to the Government.(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2026-01, effective March 13, 2026.(iv) The associated NAICS code is 541380, Testing Laboratories and Services, with a small business size standard of $19.0 million.This requirement is unrestricted.